Logo der Universitätsmedizin Mainz

Prof. Bernhard Lämmle

Professor Dr. med. Bernhard Lämmle
Professor Dr. med. Bernhard Lämmle
Funktionen:

Gastprofessor CTH, Emeritus Professor und Direktor Universitätsklinik für Hämatologie, Bern

 


Prof. Lämmle war bis zu seinem altersbedingten Rücktritt Ende Juli 2013 Direktor und Chefarzt der Universitätsklinik für Hämatologie und des Hämatologischen Zentrallabors des Inselspitals und der Universität Bern sowie ordentlicher Professor für Hämatologie. Seit Herbst 2013 ist er als Senior Professor am CTH der Universitätsmedizin Mainz tätig. Sein breites wissenschaftliches Interesse betrifft zahlreiche klinische, labordiagnostische und grundlagenwissenschaftliche Fragen der Hämatologie, Hämostase und Thrombose mit einem Schwerpunkt auf dem Gebiet der thrombotischen Mikroangiopathien, insbesondere der thrombotisch thrombozytopenischen Purpura und der Metalloprotease ADAMTS13. Bernhard Lämmle ist Autor von über 280 Publikationen und hat zahlreiche State-of-the-Art, Educational und Plenary Lectures an internationalen Kongressen gehalten. Im Juli 2017 wurde ihm von der International Society on Thrombosis and Hemostasis (ISTH) der Distinguished Career Award verliehen. In Mainz unterstützt er bestehende Forschungsgruppen und ist in der Nachwuchsförderung aktiv.

Prof. Lämmle ist gemeinsam mit Dr. von Auer (Med. III) Leiter des Translationalen Forschungsprojekts 'Thrombotische thrombozytopenische Purpura'

Originalarbeiten

  • Adenaeuer A, Barco S, Trinchero A, Lackner KJ, Lämmle B, Rossmann H. Definite diagnosis of plasma prekallikrein deficiency should not be based exclusively on shortening of the aPTT upon prolonged pre-incubation. Int J Lab Hematol. 2022 Aug;44(4):e179-e180.

     

  • Kangro K, Roose E, Joly BS, Sinkovits G, Falter T, von Auer C, Rossmann H, Reti M, Voorberg J, Prohászka Z, Lämmle B, Coppo P, Veyradier A, De Meyer SF, Männik A, Vanhoorelbeke K. Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura. Blood Adv. 2021 Sep 14;5(17):3427-3435.

     

     

  • Falter T, Rossmann H, Menge P, Goetje J, Groenwoldt S, Weinmann A, Sivanathan V, Schulz A, Lemmermann NAW, Danckwardt S, Lackner KJ, Galle PR, Scharrer I, Lämmle B, Sprinzl MF. No Evidence for Classic Thrombotic Microangiopathy in COVID-19. J Clin Med. 2021 Feb 9;10(4):671.

     

     

  • Wendt R, Kalbitz S, Otto F, Falter T, Beige J, Rossmann H, Lämmle B. Diagnosis of Hereditary TTP Caused by Homozygosity for a Rare Complex ADAMTS13 Allele After Salmonella Infection in a 43-Year-Old Asylum Seeker. Front Med (Lausanne). 2021 Feb 26;8:639441.

     

     

  • F. Alwan, C. Vendramin, U. Budde, R. Liesner, A. Taylor, M. Thomas, B. Lämmle, M. Scully. Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura. eJHaem 2021;1-8
  • R. Wendt, S. Kalbitz, F. Otto, T. Falter, J. Beige, H. Rossmann, B. Lämmle. Diagnosis of hereditary TTP caused by homozygosity for a rare complex ADAMTS13 allele after salmonella infection in a 43-year-old Asylum seeker. Frontiers in Medicine 2021;8:639441
  • T. Falter, H. Rossmann, P. Menge, J. Goetje, S. Groenwoldt, A. Weinmann, V. Sivanathan, A. Schulz, N.A.W. Lemmermann, S. Danckwardt, K.J. Lackner, P.R. Galle, I. Scharrer, B. Lämmle, M.F. Sprinzl. No evidence for classic thrombotic microangiopathy in COVID-19. J Clin Med 2021;10:671(1-16)
  • E. Tarasco, L. Bütikofer, K.D. Friedman, J.N. George, I. Hrachovinova, P.N. Knöbl, M. Matsumoto, A.S. von Krogh, I. Aebi-Huber, Z. Cermakova, M. Gorska-Kosicka, K.A. Jalowiec, C.R. Largiader, Z. Prohaszka, G. Sinkovits, J. Windyga, B. Lämmle, J.A. Kremer Hovinga. Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura. Blood 2021
  • A. Cuker, S.R. Cataland, P. Coppo, J. de la Rubia, K.D. Friedman, J.N. George, P.N. Knoebl, J.A. Kremer Hovinga, B. Lämmle, M. Matsumoto, K. Pavenski, F. Peyvandi, K. Sakai, R. Sarode, M.R. Thomas, Y. Tomiyama, A. Veyradier, J.P. Westwood, M. Scully for the International Working Group for Thrombotic Thrombocytopenic Purpura. Redefining outcomes in immune TTP: An international working group consensus report. Blood 2021
  • B. Lämmle. Endothelial dysfunction, atherosclerosis, and increase of Von Willebrand factor and Factor VIII: a randomized controlled trial in swine. Invited Thrombosis and Haemostasis Insights. Thromb Haemost 2021; in press
  • S. Sukumar, B. Lämmle, S.R. Cataland. Thrombotic thrombocytopenic purpura: Pathophysiology, diagnosis, and management. J Clin Med 2021;10:536(1-24)
  • T. Falter, S. Böschen, M. Schepers, M. Beutel, K. Lackner, I. Scharrer, B. Lämmle. Influence of personality, resilience, and life conditions on depression and anxiety in 104 patients having survived acute autoimmune thrombotic thrombocytopenic purpura. J Clin Med 2021;10:365 (1-14)
  • L.C. Velasquez Pereira, E. Roose, N.A.G. Graça, G. Sinkovits, K. Kangro, B.S. Joly, E. Tellier, G. Kaplanski, T. Falter, C. von Auer, H. Rossmann, H.B. Feys, M. Reti, Z Prohaszka, B. Lämmle, J.Voorberg, P. Coppo, A. Veyradier, S.F. De Meyer, A. Männik, K. Vanhoorelbeke. Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura. J Thromb Haemost 2021;19:478-488
  • A. Adenaeuer, E.D. Ezigbo, H.F. Nazir, S. Barco, A. Trinchero, D. Laubert-Reh, K. Strauch, P.S. Wild, K.J. Lackner, B. Lämmle, H. Rossmann. c.451dupT in KLKB1 is common in Nigerians, confirming a higher prevalence of severe prekallikrein deficiency in Africans compared to Europeans. J Thromb Haemost 2021;19:147-152
  • S. Tanabe, Y. Fujimura, B. Lämmle, T. Kimura, A. Isonishi, K. Sakai, M. Matsumoto. Stealth thrombosis of brain and kidney in a girl with Upshaw-Schulman syndrome not receiving prophylactic plasma infusions. Image in Hematology. Int J Hematol 2020;112:603-604
  • P. Keller, R. von Känel, C.A. Hincapié, B.R. da Costa, P. Jüni, T.E. Erlanger, N. Andina, C. Niederhauser, B. Lämmle, S. Fontana. The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial. Scientific Reports 2020;10:14219
  • B. Lämmle. Clinical problem solving and using new paths in the laboratory: Learning from case studies. Hämostaseologie-Progress in Haemostasis 2020;40:414-419
  • B. Lämmle. Hot Topic: TTP. Hämostase Update 2020. 5. Hämophilie-Update- und Hämostaseologie Update-Seminar, 19./20. Juni 2020
  • R. Escher, N. Breakey, B. Lämmle. ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients. Thromb Res 2020;192:174-175
  • R. Escher, N. Breakey, B. Lämmle. Severe COVID-19 infection associated with endothelial activation. Letter. Thromb Res 2020;190:62.
  • Keller P, von Kanel R, Hincapie CA, da Costa BR, Juni P, Erlanger TE, Andina N, Niederhauser C, Lämmle B, Fontana S. 2020. The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial. Sci Rep 10:14219.
  • Roose E, Schelpe AMB, Tellier E, Sinkovits G, Joly BS, Dekimpe C, Kaplanski G, Le Besnerais M, Mancini I, Falter DT, von Auer C, Feys HB, Reti M, Rossmann H, Vandenbulcke A, Pareyn I, Voorberg J, Greinacher A, Benhamou Y, Deckmyn H, Fijnheer RR, Prohaszka Z, Peyvandi F, Lämmle B, Coppo P, De Meyer S, Veyradier A, Vanhoorelbeke K. Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura. Blood 2020.
  • Gresele P, Orsini S, Noris P, Falcinelli E, Alessi MC, Bury L, Borhany M, Santoro C, Glembotsky AC, Cid AR, Tosetto A, De Candia E, Fontana P, Guglielmini G, Pecci A, Bat-Val study Investigators Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC. J Thromb Haemost 2020;18(3):732-739.
  • Barco S, Sollfrank S, Trinchero A, Adenaeuer A, Abolghasemi H, Conti L, Hauser F, Kremer Hovinga JA, Lackner KJ, Loewecke F, Miloni E, Vazifeh Shiran N, Tomao L, Wuillemin WA, Zieger B, Lämmle B, Rossmann H. Severe Plasma Prekallikrein Deficiency: Clinical Characteristics, Novel KLKB1 Mutations, and Estimated Prevalence. J Thromb Haemost 2020. [Epub ahead of print]

  • Klingenberg R, Schlager O, Limacher A, Mean M, Vuilleumier N, Beer JH, Staub D, Frauchiger B, Aschwanden M, Lämmle B, Righini M, Egloff M, Osterwalder J, Angelillo-Scherrer A, Kucher N, Banyai M, Rodondi N, von Eckardstein A, Aujesky D, Husmann M, Matter CM. Risk stratification of elderly patients with acute pulmonary embolism. Eur J Clin Invest 2019;49(9):e13154.
  • Fujimura Y, Lämmle B, Tanabe S, Sakai K, Kimura T, Kokame K, Miyata T, Takahashi Y, Taniguchi S, Matsumoto M. Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome. Blood Adv 2019;3(21):3191-3195.
  • van Dorland HA, Mansouri Taleghani M, Sakai K, Friedman KD, George JN, Hrachovinova I, Knöbl PN, von Krogh AS, Schneppenheim R, Aebi-Huber I, Bütikofer L, Largiadèr CR, Cermakova Z, Kokame K, Miyata T, Yagi H, Terrell DR, Vesely SK, Matsumoto M, Lämmle B, Fujimura Y, Kremer Hovinga JA; Hereditary TTP Registry. The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: Key findings at enrolment until 2017. Haematologica. 2019 Feb 21. pii: haematol.2019.216796. doi: 10.3324/haematol.2019.216796. [Epub ahead of print]
  • Lauber S, Limacher A, Tritschler T, Stalder O, Mean M, Righini M, Aschwanden M, Beer JH, Frauchiger B, Osterwalder J, Kucher N, Lämmle B, Cornuz J, Angelillo-Scherrer A, Matter CM, Husmann M, Banyai M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky D. Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients. Am J Med 2018;131(6):703 e7-703 e16.
  • Jimenez-Alcazar M, Limacher A, Panda R, Mean M, Bitterling J, Peine S, Renne T, Beer JH, Aujesky D, Lämmle B, Fuchs TA. Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolism. PLoS One 2018;13(2):e0191150.
  • Falter T, Herold S, Weyer-Elberich V, Scheiner C, Schmitt V, von Auer C, Messmer X, Wild P, Lackner KJ, Lämmle B, Scharrer I. Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab. Thromb Haemost 2018;118(10):1743-1751.
  • Colucci G, Helsing K, Biasiutti FD, Raio L, Schmid P, Tsakiris DA, Eberle B, Surbek D, Lämmle B, Alberio L. Standardized Management Protocol in Severe Postpartum Hemorrhage: A Single-Center Study. Clin Appl Thromb Hemost 2018;24(6):884-893.
  • Seiler E, Limacher A, Mean M, Beer HJ, Osterwalder J, Frauchiger B, Righini M, Aschwanden M, Matter CM, Banyai M, Kucher N, Staub D, Lämmle B, Rodondi N, Squizzato A, Aujesky D. Derivation and validation of a novel bleeding risk score for elderly patients with venous thromboembolism on extended anticoagulation. Thromb Haemost 2017;117(10).
  • Trinchero A, Schotten S, Lämmle B, Pitton MB (2017) May-Thurner syndrome: missed diagnosis and missed early treatment? Hamostaseologie 37: 184-185
  • Faller N, Limacher A, Mean M, Righini M, Aschwanden M, Beer JH, Frauchiger B, Osterwalder J, Kucher N, Lämmle B, Cornuz J, Angelillo-Scherrer A, Matter CM, Husmann M, Banyai M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky D (2017) Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study. Am J Med 130: 198-206
  • Falter T, Schmitt V, Herold S, Weyer V, von Auer C, Wagner S, Hefner G, Beutel M, Lackner K, Lämmle B, Scharrer I (2017) Depression and cognitive deficits as long-term consequences of thrombotic thrombocytopenic purpura. Transfusion 57: 1152-1162
  • Jäckel S, Kiouptsi K, Lillich M, Hendrikx T, Khandagale A, Kollar B, Hörmann N, Reiss C, Subramaniam S, Wilms E, Ebner K, von Brühl ML, Rausch P, Baines JF, Haberichter S, Lämmle B, Binder CJ, Jurk K, Ruggeri ZM, Massberg S et al. (2017) Gut microbiota regulate hepatic von Willebrand Factor synthesis and arterial thrombus formation via Toll-like receptor-2. Blood 130(4):542-553
  • Mean M, Limacher A, Stalder O, Angelillo-Scherrer A, Alberio L, Fontana P, Beer HJ, Rodondi N, Lämmle B, Aujesky D (2017) Do factor V Leiden and prothrombin G20210A mutations predict recurrent venous thromboembolism in older patients? Am J Med 130(10):1220.e17-1220.e22
  • Scully M, Cataland S, Coppo P, de la Rubia J, Friedman KD, Kremer Hovinga J, Lämmle B, Matsumoto M, Pavenski K, Sadler E, Sarode R, Wu H, International Working Group for Thrombotic Thrombocytopenic P (2017) Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. Journal of thrombosis and haemostasis 15: 312-322
  • Nagler M, Kremer Hovinga JA, Alberio L, Peter-Salonen K, von Tengg-Kobligk H, Lottaz D, Neerman-Arbez M, Lämmle B (2016) Thromboembolism in patients with congenital afibrinogenaemia. Long-term observational data and systematic review. Thrombosis and haemostasis 116: 722-32
  • von Krogh AS, Quist-Paulsen P, Waage A, Langseth OO, Thorstensen K, Brudevold R, Tjonnfjord GE, Largiader CR, Lämmle B, Kremer Hovinga JA. High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence. Journal of thrombosis and haemostasis 14:73-82. 2016.
  • Segna D, Mean M, Limacher A, Baumgartner C, Blum MR, Beer JH, Kucher N, Righini M, Matter CM, Frauchiger B, Cornuz J, Aschwanden M, Banyai M, Osterwalder J, Husmann M, Egloff M, Staub D, Lämmle B, Angelillo-Scherrer A, Aujesky D, Rodondi N. 2016. Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study. Journal of thrombosis and haemostasis. 14: 685-94. 2016. 
  • Insam C, Mean M, Limacher A, Angelillo-Scherrer A, Aschwanden M, Banyai M, Beer JH, Bounameaux H, Egloff M, Frauchiger B, Husmann M, Kucher N, Lämmle B, Matter C, Osterwalder J, Righini M, Staub D, Rodondi N, Aujesky D. Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research Study. PloS one 11:e0148348. 2016.
  • Fan X, Kremer Hovinga JA, Shirotani-Ikejima H, Eura Y, Hirai H, Honda S, Kokame K, Taleghani MM, von Krogh AS, Yoshida Y, Fujimura Y, Lämmle B, Miyata T. Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency. International journal of hematology 103:283-291. 2016.
  • von Krogh AS, Kremer Hovinga JA, Romundstad PR, Roten LT, Lämmle B, Waage A, Quist-Paulsen P. ADAMTS13 gene variants and function in women with preeclampsia: A population- based nested case- control study from the HUNT Study. Thrombosis research. 2015.
  • Kurmann R, Weisstanner C, Kardas P, Hirsch HH, Wiest R, Lämmle B, Furrer H, Du Pasquier R, Bassetti CL, Sturzenegger M, Krestel H.  Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine. Journal of neurovirology. 21: 694-701. 2015.
  • von Känel R, Margani A, Stauber S, Meyer FA, Demarmels Biasiutti F, Vökt F, Wissmann T, Lämmle B, Lukas PS. Depressive symptoms as a novel risk factor for recurrent venous thromboembolism: a longitudinal observational study in patients referred for thrombophilia investigation. PloS one. 10:e0125858, 2015.
  • Jiang Y, McIntosh JJ, Reese JA, Deford CC, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, Knudtson EJ, George JN. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood. 123:1674-1680, 2014.
  • Jimenez-Alcazar M, Napirei M, Panda R, Köhler EC, Kremer-Hovinga JA, Mannherz HG, Peine S, Renné T, Lämmle B, Fuchs TA. Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies. Journal of thrombosis and haemostasis. 13: 732-42. 2014.
  • Stroka D, Keogh A, Vu D, Fort A, Stoffel MH, Kühni-Boghenbor K, Furer C, Banz V, Demarmels Biasiutti F, Lämmle B, Candinas D, Neerman-Arbez M. In vitro rescue of FGA deletion by lentiviral transduction of an afibrinogenemic patient's hepatocytes. Journal of thrombosis and haemostasis. 12: 1874-9. 2014.
  • von Krogh AS, Kremer Hovinga JA, Tjonnfjord GE, Ringen IM, Lämmle B, Waage A, Quist-Paulsen P. The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications. Thrombosis and haemostasis. 111:1180-1183, 2014.

Reviews / Editorials / Kommentare

  • Lämmle B. A third form of thrombotic thrombocytopenic purpura? Haematologica. 2022 Apr 28
  • Adenaeuer A, Barco S, Trinchero A, Lackner KJ, Lämmle B, Rossmann H. Definite diagnosis of plasma prekallikrein deficiency should not be based exclusively on shortening of the aPTT upon prolonged pre-incubation. Int J Lab Hematol. 2022 Aug;44(4):e179-e180.
  • Ten Cate H, Lämmle B. Special Issue: "The Latest Clinical Advances in Thrombocytopenia". J Clin Med. 2021 Aug 5;10(16):3463.
  • Lämmle B, Rossmann H. Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research. Thromb Res. 2021 Aug;204:141-142.

     

     

  • Lämmle B. Endothelial Dysfunction, Atherosclerosis, and Increase of Von Willebrand Factor and Factor VIII: A Randomized Controlled Trial in Swine. Thromb Haemost. 2021 May;121(5):552.

     

     

  • Lämmle B. Clinical Problem Solving and Using New Paths in the Laboratory: Learning from Case Studies. Hamostaseologie. 2020 Nov;40(4):414-419.
  • Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res 2020;190:62.
  • d'Alessandro E, Becker C, Bergmeier W, Bode C, Bourne JH, Brown H, Buller HR, Ten Cate-Hoek AJ, Ten Cate V, van Cauteren YJM, Cheung YFH, Cleuren A, Coenen D, Crijns H, de Simone I, Dolleman SC, Klein CE, Fernandez DI, Granneman L, van THA, Henke P, Henskens YMC, Huang J, Jennings LK, Jooss N, Karel M, van den Kerkhof D, Klok FA, Kremers B, Lämmle B, Leader A, Lundstrom A, Mackman N, Mannucci PM, Maqsood Z, van der Meijden PEJ, van Moorsel M, Moran LA, Morser J, van Mourik M, Navarro S, Neagoe RAI, Olie RH, van Paridon P, Posma J, Provenzale I, Reitsma PH, Scaf B, Schurgers L, Seelig J, Siegbahn A, Siegerink B, Soehnlein O, Soriano EM, Sowa MA, Spronk HMH, Storey RF, Tantiwong C, Veninga A, Wang X, Watson SP, Weitz J, Zeerleder SS, Ten Cate H, Scientific Reviewer C. Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis. Thromb Haemost 2020;120(4):538-564.
  • Coppo P, Lämmle B. Animal models of thrombotic thrombocytopenic purpura: the tales from zebrafish. Haematologica 2020;105(4):861-863.
  • Lämmle B. Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: Pathophysiology and Differentiation from Graft versus Host Disease. Thromb Haemost 2019;119(9):1382.
  • Lämmle B (2017) Opana ER-induced thrombotic microangiopathy. Blood 129: 808-809
  • Kremer Hovinga JA, Coppo P, Lämmle B, Moake JL, Miyata T, Vanhoorelbeke K (2017) Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers 3: 17020
  • B. Lämmle. Commentary on Peyvandi, F. et al. Caplacizumab for acquired thrombotic thrombocytopenic purpura. N. Engl. J. Med. 374,511-522(2016). News and Views. Nature Rev Nephrology 2016;12:259-260
  • Nagler M, Kremer Hovinga JA, Alberio L, Peter-Salonen K, von Tengg-Kobligk H, Lottaz D, Neerman-Arbez M, Lämmle B (2016) Thromboembolism in patients with congenital afibrinogenaemia. Long-term observational data and systematic review. Thrombosis and haemostasis 116: 722-32.
  • Lämmle B. Thrombotic microangiopathy: Caplacizumab accelerates resolution of acute acquired TTP. Nature reviews. Nephrology 12:259-260. 2016.
  • Lämmle B. VWF and complement. Blood. 125:896-898, 2015.
  • von Auer C, von Krogh AS, Kremer Hovinga JA, Lämmle B. Current insights into thrombotic microangiopathies: Thrombotic thrombocytopenic purpura and pregnancy. Thrombosis research. 135 Suppl 1:S30-33, 2015.
  • Lämmle B, Walter U.  Pearls, guidelines & more. Hamostaseologie. 34:199, 2014.

Buchbeitrag

Bernhard Lämmle and Charis von Auer

Chapter 1 - History of Thrombotic Thrombocytopenic Purpura and the von Willebrand Factor–Cleaving Protease, ADAMTS13.

ADAMTS13 - Biology and Diesease, Editor George M. Rodgers (Springer), ISBN 978-3-319-08716-0


Februar 2021

Die Gesellschaft für Thrombose und Hämostase (GTH) verleiht Prof. Lämmle aufgrund seiner außerordentlichen klinischen und wissenschaftlichen Leistungen für die Fachgesellschaft und insbesondere auch für sein Engagement am CTH in Mainz die Ehrenmitgliedschaft der GTH. Link